• No results found

Comparative Evaluation of the Efficacy of the Bimatoprost 0 03%, Brimonidine 0 2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0 004%/Timolol 0 5% Fixed Combinations in Patients Affected by Open Angle Glaucoma

N/A
N/A
Info
Download
Protected

Academic year: 2020

Share "Comparative Evaluation of the Efficacy of the Bimatoprost 0 03%, Brimonidine 0 2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0 004%/Timolol 0 5% Fixed Combinations in Patients Affected by Open Angle Glaucoma"

Copied!
5
0
0

Loading.... (view fulltext now)

Download now ( 5 Page )

Full text

Loading

Figure

Table 2. Fixed combinations (Number of patients).
Table 4. Results.

References

Download now ( PDF - 5 Page - 209.69 KB )

Related documents

A Comparative Evaluation of Efficacy and Tolerability of Fixed Drug Combination of Brimonidine and Timolol with Timolol Monotherapy in Patients with Primary Open-Angle Glaucoma: An Open Labeled Prospective Study

I hereby declare that this dissertation entitled in “A comparative evaluation of efficacy and tolerability of Fixed drug combination of Brimonidine and Timolol

Study of ocular hypotensive effect and tolerability of fixed-combination Brinzolamide 1% and brimonidine 0.2% in Indian eyes with open angle glaucoma

This study aims to assess the ocular hypotensive effect and tolerability of fixed combination of brinzolamide 1% and brimonidine 0.2% in Indian patients with Open

Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension

 PURPOSE: To assess the intraocular pressure (IOP)- lowering effects and safety of a carteolol/latanoprost fixed combination drug (OPC-1085EL) vs latanoprost (Study 1) and

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue

In the previous report, we examined the efficacy of travoprost/timolol fixed combination (TTFC: DuoTrav ® , Alcon Laboratories, Inc., Fort Worth, TX, USA) in patients

Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

A total of 227 patients were randomized to either a once-daily, BAK-free, fixed-dose combination of latanoprost 0.005%/timolol 0.5% ophthalmic solution or concomitant

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension

Background: The purpose of this study was to evaluate the efficacy and safety of two fixed combinations, ie, timolol 0.5% + brimonidine 0.2% + dorzolamide 2% (TBD) versus timolol

Efficacy and safety of topical 2% dorzolamide and 0.5% timolol in cases of open angle glaucoma in a tertiary care hospital of East Singhbhum: an observational, prospective and comparative study

• Patients had glaucoma other than primary open angle, other ocular diseases or history of intraocular surgery. • Patients on systemic beta-blockers. a) Group IA and IIA- 2%